EKEiichi Kakehi

Eiichi Kakehi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eiichi Kakehi has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Kazuhiko Kotani

    Division of Community and Family Medicine; Jichi Medical University; Tochigi Japan

    9 shared publications
  • Seiji Adachi

    Department of General Medicine, Tottori Municipal Hospital, Tottori, Japan

    8 shared publications
  • Akane Hirotani

    Department of General Medicine, Tottori Municipal Hospital, Tottori, Japan

    6 shared publications
  • Shigehisa Sakurai

    Department of General Medicine, Tottori Municipal Hospital, Tottori, Japan

    6 shared publications
  • Keisuke Shoji

    Department of General Medicine, Tottori Municipal Hospital, Tottori, Japan

    5 shared publications
  • Masami Matsumura

    Center for Community Medicine, Jichi Medical University, Shimotsuke-City, Tochigi, Japan

    5 shared publications

Latest Publications

  • Open Access

    Autoimmune Gastritis Diagnosed Through Iron-Deficiency Anemia and Gastric Neuroendocrine Tumors in an Older Adult: A Case Report

    by Eiichi Kakehi, Gaku Shimazaki, You Nabika, Kazuhiko Kotani

    Background and Clinical Significance: Autoimmune gastritis (AIG) can cause iron-deficiency anemia (IDA) before vitamin B12 deficiency develops. Although AIG-associated IDA is more common in younger individuals, it can also occur in older adults. Type 1 gastric neuroendocrine tumors (gNETs) associated with hypergastrinemia may indicate previously unrecognized AIG; Case Presentation: A 72-year-old woman was referred for microcytic anemia. Laboratory tests revealed severe IDA, with hemoglobin of 4.7 g/dL, mean corpuscular volume of 56 fL, and ferritin of 3.2 ng/mL, despite normal vitamin B12 levels. Gastrointestinal endoscopy identified no bleeding source but revealed extensive gastric mucosal atrophy and a 5 mm gastric lesion. Histopathological examination confirmed a grade 1 gNET. Probable AIG was diagnosed based on a composite clinical assessment of corpus-predominant endoscopic atrophy, anti-parietal cell antibody positivity, and marked hypergastrinemia (1147.2 pmol/L) in the absence of acid-suppressive therapy, although biopsies did not clearly demonstrate the characteristic corpus-predominant histological pattern. The NET G1 was therefore considered consistent with a type 1 gNET. Although the initial biopsy suggested Helicobacter pylori infection, subsequent histology, gastric mucosal polymerase chain reaction, and serum antibody testing were negative. Anemia improved after red blood cell transfusion and intravenous iron therapy. The gNET was completely resected endoscopically. A second gNET detected during follow-up was also completely resected; Conclusions: AIG should be considered in older adults with unexplained IDA, even without vitamin B12 deficiency or macrocytic anemia. A gNET may provide an important clue to underlying AIG. In this case, the diagnosis of probable AIG represented a composite clinical judgment, given the absence of definitive histological findings. Even when H. pylori infection is suspected, gastric mucosal atrophy should not be attributed solely to H. pylori-associated gastritis, and coexisting AIG should be evaluated using integrated serological, endoscopic, and histopathological findings.

  • Open Access

    Functional Independence Measure assessed early after admission predicts home discharge in older adults admitted to acute general medical wards: a retrospective cohort study

    by Eiichi Kakehi, Yukako Matsumoto, Kyoichiro Namura, Kae Sugiyama, Yukinobu Akamatsu, Shigehisa Sakurai, Takafumi Nozaki, Keisuke Shoji, Seiji Adachi, Kazuhiko Kotani

    Objective: To examine whether Functional Independence Measure (FIM) scores assessed during the early phase of hospitalisation, before the initiation of rehabilitation, independently predict home discharge among older adults admitted to an acute general medical ward. Design: Retrospective observational cohort study. Setting: The General Medicine Department of a municipal general hospital in Japan. Participants: Of 1168 community-dwelling adults aged ≥65 years admitted from home, the study included 744 who received rehabilitation and underwent early-phase FIM assessment before rehabilitation. Main outcome measures: The primary outcome was the discharge destination (home vs facility). The predictive value of the total FIM score (FIM-T), motor score (FIM-M) and cognitive score (FIM-C) was evaluated using multivariable logistic regression and receiver operating characteristic (ROC) curve analyses. Results: Overall, 494 patients (66.4%) were discharged home, 175 were discharged to facilities, and 75 died in hospital. The admission FIM was measured during the early phase of hospitalisation, with a mean assessment time of 4 days after admission. Early-phase FIM scores were significantly higher in the home discharge group than the facility discharge group (FIM-T: 65.8 vs 44.8; FIM-M: 38.1 vs 23.1; FIM-C: 27.7 vs 21.8; all p<0.001). After adjustment for age, clinical variables and social factors, higher FIM-T, FIM-M and FIM-C scores remained independently associated with home discharge (adjusted OR per 1-point increase for FIM-T: 1.06). ROC analysis showed moderate discriminative ability (areas under the curve of 0.75 for FIM-T and FIM-M, and 0.71 for FIM-C). Conclusions: Early-phase FIM scores, including both motor and cognitive domains, independently predict home discharge among older adults in acute general medical wards and may support individualised discharge planning in routine practice. These findings may be most generalisable to acute care hospitals where early-phase functional assessments are performed at the initial rehabilitation evaluation, which, in our setting, occurred a mean of 4 days after admission.

  • Linked color imaging versus conventional white-light colonoscopy for the detection of colorectal polyps

    by Jun Watanabe, Takeshi Kanno, Eiichi Kakehi, Kazuma Rifu, Takehiro Kagaya, Kazuhiko Kotani, Yuki Kataoka

    Rationale Early detection of colorectal polyps using colonoscopy is important for preventing post‐colonoscopy colorectal cancer (PCCRC) because a 1% increase in adenoma detection rate (ADR) is associated with a 3% decrease in PCCRC incidence. Linked color imaging (LCI) enhances color contrast compared to white‐light imaging (WLI), potentially improving ADR. Existing reviews provide promising yet inconclusive findings on LCI’s benefits, highlighting the need for this systematic review. Objectives To assess the benefits and harms of LCI compared to WLI colonoscopy in detecting colorectal polyps in people requiring colonoscopy for screening, symptoms, or surveillance. Search methods We searched CENTRAL, MEDLINE, Embase, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform from 2014 to 30 May 2025. We screened the reference lists of relevant review articles and current treatment guidelines to identify additional studies. We contacted the study authors in case of any missing data. Eligibility criteria We included randomized controlled trials (RCTs) comparing LCI and WLI. We excluded non‐RCTs. We included adults 18 years of age and older who required colonoscopy for screening, symptom assessment, and surveillance in any healthcare setting. Outcomes The critical outcomes were ADR during the study period, proportion of participants with PCCRC at next scheduled follow‐up colonoscopy, and proportion of adverse events requiring medical treatment during the study period. Important outcomes were polyp detection rate and sessile serrated lesion detection rate during the study period, numbers of adenomas, polyps, and flat polyps per participant at the end of a single colonoscopy, and all adverse events during the study period. Risk of bias Two authors assessed study risk of bias using version two of the Cochrane tool for assessing risk of bias in randomized trials (RoB 2). Synthesis methods We synthesized results for each outcome using random‐effects meta‐analysis, calculating risk ratios (RRs) for dichotomous outcomes and mean differences (MDs) for continuous outcomes, each with 95% confidence intervals (CIs), using Review Manager. Where meta‐analysis was not possible due to data heterogeneity or insufficient reporting, we applied the Synthesis Without Meta‐analysis (SWiM) approach. We used GRADE to assess the certainty of the evidence. Included studies We included 16 trials, with 12,836 participants. Nine trials focused on screening/surveillance and seven on screening and symptomatic patients. We judged six trials as being at low risk of bias overall. Synthesis of results Critical outcomes LCI slightly increases ADR compared to WLI (RR 1.18, 95% CI 1.10 to 1.28; 15 RCTs, 12,877 participants; high‐certainty evidence). No study reported the proportion of participants with PCCRC. There were no adverse events requiring medical treatment (6 RCTs, 5240 participants; moderate‐certainty evidence). Important outcomes LCI slightly increases polyp detection rate (RR 1.14, 95% CI 1.09 to 1.19; 12 RCTs, 11,243 participants; high‐certainty evidence), and likely increases sessile serrated lesion detection rate (RR 1.61, 95% CI 1.31 to 1.98; 7 RCTs, 8605 participants; moderate‐certainty evidence), and the number of adenomas per participant (MD 0.18, 95% CI 0.03 to 0.32; 11 RCTs, 10,833 participants; moderate‐certainty evidence). A key limitation of the evidence was imprecision for sessile serrated lesion detection and number of adenomas per participant due to small sample sizes. Similarly, zero events were reported for adverse events requiring medical treatment, limiting precision despite adequate sample sizes. Additionally, no study reported the proportion of participants with PCCRC, further restricting our conclusions. Authors' conclusions We found high‐certainty evidence that LCI slightly increases ADR and moderate‐certainty evidence that LCI likely results in little to no difference in the proportion of adverse events requiring medical treatment; data on the proportion of participants with PCCRC are unavailable. We also found high‐certainty evidence that LCI slightly improves polyp detection rate and moderate‐certainty evidence that LCI likely increases sessile serrated lesion detection rate and the number of adenomas and polyps per participant. Further studies should focus on measuring clinically significant outcomes, such as the proportion of participants with PCCRC. Funding This study had no dedicated funding. Registration Protocol available via DOI 10.1002/14651858.CD015476.


  • Anti-neutrophil cytoplasm antibody-negative eosinophilic granulomatous polyangiitis complicated by myositis: a case report

    by Naoki Nakagawa, Eiichi Kakehi, Kazuhiko Kotani

    A 31-year-old woman visited our hospital with swelling and pain in both forearms of 2 months’ duration, followed by swelling and pain in both thighs. Her medical history included bronchial asthma at the age of 18 years. After the birth of her first child at 30 years of age, her asthma worsened and was accompanied by abdominal pain and skin rash, with no identifiable cause. Blood testing showed eosinophilia and high muscle enzyme activities, but she was anti-neutrophilic cytoplasmic antibody (ANCA)-negative. Magnetic resonance imaging of her forearms and thighs revealed strong signals on T2-weighted images in the fascia and muscle. Skin-to-muscle en bloc biopsy showed eosinophilic infiltration of muscle and small vessels. She was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA), complicated by myositis, although EGPA is usually accompanied by ANCA-positivity in approximately half of cases. Treatment was started with prednisolone alone at 0.5 mg/kg/day, and her symptoms and eosinophil count quickly improved. Clinicians should note the possibility of ANCA-negative EGPA complicated by myositis.


  • Open Access

    Utility of the New Early Warning Score (NEWS) in combination with the neutrophil–lymphocyte ratio for the prediction of prognosis in older patients with pneumonia

    by Eiichi Kakehi, Ryo Uehira, Nobuaki Ohara, Yukinobu Akamatsu, Taeko Osaka, Shigehisa Sakurai, Akane Hirotani, Takafumi Nozaki, Keisuke Shoji, Seiji Adachi, et al.

    Objective Predictors of prognosis are necessary for use in routine clinical practice for older patients with pneumonia, given the ageing of the population. Recently, the National Early Warning Score (NEWS), a comprehensive predictor of severity that consists solely of physiological indicators, has been proposed to predict the prognosis of pneumonia. The neutrophil/lymphocyte ratio (NLR) is a simple index of inflammation that may also be predictive of pneumonia. In the present study, we aimed to determine whether NEWS or a combination of NEWS and NLR predicts mortality in older patients with pneumonia. Design A retrospective cohort study. Setting A general hospital in Japan. Participants We collected data from patients aged ≥65 years with pneumonia who were admitted between 2018 and 2020 (n=282; age=85.3 (7.9)). Data regarding vital signs, demographics and the length of hospital stay, in addition to the NEWS and NLR, were extracted from the participants’ electronic medical records. Intervention The utility of the combination of NEWS and NLR was assessed using NEWS×NLR and NEWS+NLR. Main outcome measures Their predictive ability for 30-day mortality as the primary outcome was assessed using receiver operating characteristic (ROC) curve analysis. Results According to the NEWS classification, 80 (28.3%), 64 (22.7%) and 138 (48.9%) of the participants were at low, medium and high risk of mortality, respectively. The 30-day mortality for the entire cohort was 9.2% (n=26), and the mortality rate increased with the NEWS classification: low, 1.3%; medium, 7.8%; and high, 14.5%. The NLRs were 6.0 (4.2–9.8), 6.8 (4.8–10.4) and 14.6 (9.4–22.2), respectively (pConclusions A combination of the NEWS and NLR (NEWS×NLR or NEWS+NLR) may be superior to the NEWS alone for the prediction of 30-day mortality in older patients with pneumonia. However, further validation of these combinations for use in the prediction of prognosis is required.


  • Open Access

    Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination

    by Kohsuke Ikeda, Eiichi Kakehi, Seiji Adachi, Kazuhiko Kotani

    A previously healthy Japanese woman in her 20s was admitted to our hospital with a 2-week history of fever (39.0°C) and a 1-week history of painful cervical lymphadenopathy. The day before fever onset, she had received her first Pfizer-BioNTech SARS-CoV-2 vaccine in her left arm. She had previously been treated with empirical antibiotics with no improvement. Physical examination revealed painful lymphadenopathy in both posterior cervical regions. CT showed symmetrical lymphadenopathies in the neck, supraclavicular, axillary and inguinal regions as well as hepatosplenomegaly. We suspected lymphoma and performed a lymph node biopsy in the right inguinal region, which revealed necrotising histiocytic lymphadenitis. The patient was, therefore, diagnosed with Kikuchi-Fujimoto disease (KFD). She improved after the corticosteroid therapy. This report highlights the importance of including KFD as a differential diagnosis of lymphadenopathy after SARS-CoV-2 vaccination. Additionally, lymph node biopsy is helpful for diagnosing KFD because it rules out other entities.


  • Open Access

    Reversible cerebral vasoconstriction syndrome associated with tetrodotoxin poisoning: A case report

    by Eiichi Kakehi, Makoto Matsumoto, Shohei Taniguchi, Yukinobu Akamatsu, Shigehisa Sakurai, Akane Hirotani, Takafumi Nozaki, Keisuke Shoji, Seiji Adachi, Kazuhiko Kotani, et al.


  • Open Access

    Development of Acute Inflammatory Demyelinating Polyneuropathy 11 Days after Spinal Surgery: A Case Report and Literature Review

    by Eiichi Kakehi, Tadataka Kawakami, Yukiko Ishikawa, Takashi Matsuoka, Naoki Nakagawa, Tugutake Morishita, Shohei Taniguchi, Yukinobu Akamatsu, Shigehisa Sakurai, Akane Hirotani, et al.

    Guillain-Barre syndrome (GBS) usually has a good prognosis; however, patients may develop sequelae without prompt treatment. We herein describe an 81-year-old woman who developed acute-onset excruciating thigh pain and weakness in her lower extremities after spinal surgery. We diagnosed acute inflammatory demyelinating polyradiculoneuropathy by a nerve conduction study, which showed findings of demyelination without cerebrospinal fluid analysis because of a spinal prosthesis. Although anti-GM1 and anti-GalNAc-GD1a antibodies were positive, the patient was clinically diagnosed with acute inflammatory demyelinating polyradiculoneuropathy (a subtype of GBS), not acute motor axonal neuropathy. She recovered well with immunoglobulin therapy. A literature review of 18 cases revealed that unexplained weakness, areflexia, and numbness of the extremities after spinal surgery, a shorter time from spinal surgery to symptom onset to general GBS, abnormal nerve conduction study results, normal spinal imaging findings, and the development of atypical symptoms such as cranial and autonomic nerve syndrome and respiratory failure are useful for diagnosing GBS when cerebrospinal fluid examination cannot be performed after spinal surgery.


  • Response to: Kimura’s disease: effects of age on clinical presentation

    by E Kakehi, K Kotani, Y Otsuka, Y Fukuyasu, Y Hashimoto, S Sakurai, A Hirotani, K Simizu, R Fujita, K Shoji, et al.


  • Open Access

    Older-age onset of Kimura’s disease

    by Eiichi Kakehi, Kazuhiko Kotani, Tsubasa Yoshida, Tsubasa Nakai, Shigehisa Sakurai, Akane Hirotani, Kaduyo Simizu, Takafumi Nozaki, Keisuke Shoji, Seiji Adachi, et al.

    A 60-year-old man was admitted to our hospital with bilateral post auricular masses, first noticed 1 year earlier. Blood tests showed eosinophilia and high immunoglobulin E (IgE) levels, and cervical computed tomography showed 10-mm soft tissue masses with scattered lymphadenopathy. The tumors showed intermediate and high signal intensity on T1- and T2-weighted cervical magnetic resonance imaging, respectively. After mass resection, the tumors were diagnosed as Kimura’s disease (KD). Generally, KD affects young men; however, even in older patients, KD should be included as a differential diagnosis for head and neck tumors in patients with eosinophilia and high IgE.